2008
DOI: 10.1378/chest.07-0141
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Cough Across Different Chronic Respiratory Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
26
2
2

Year Published

2009
2009
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 106 publications
(34 citation statements)
references
References 18 publications
2
26
2
2
Order By: Relevance
“…Ten of them were validation studies concerning cough frequency monitoring in children and/or adults [12,13,14,15,16,17,18,19,20,21]. Seven studies validating cough-specific quality-of-life scores were included [22,23,24,25,26,27,28,29]. …”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Ten of them were validation studies concerning cough frequency monitoring in children and/or adults [12,13,14,15,16,17,18,19,20,21]. Seven studies validating cough-specific quality-of-life scores were included [22,23,24,25,26,27,28,29]. …”
Section: Resultsmentioning
confidence: 99%
“…A Dutch translation has also been validated [22]. The Cough Quality of Life Questionnaire (CQLQ) was developed and validated in English [26,28,29]. One scale has been validated in the parents of children suffering from chronic cough in Australia [27], and 1 scale was developed and validated in Italian [23,24].…”
Section: Resultsmentioning
confidence: 99%
“…Our patient had been unsuccesfully treated for 18 years (1998-2016) before her cough was significantly reduced due to the speech therapy. Although in most patients CC is a symptom of non-life-threatening disease, it significantly lowers quality of life, in both physical and psychosocial domain [1,5]. In many aspects the decrease of life quality in patients with CC is comparable to that experienced by patients with the chronic obstructive lung disease [1].…”
Section: Discussionmentioning
confidence: 99%
“…According to ACCP recommendations, unexplained chronic cough (UCC) is diagnosed in as many as 5-10% of all adults with CC [4]. Persistent CC significantly impairs the quality of life [5].…”
Section: Introductionmentioning
confidence: 99%
“…One additional study was identified by hand-searching the Novartis Pharmaceuticals submission. 60 However, of these, only five studies 111,[124][125][126][127] reported sufficient information through which to directly estimate a utility decrement for specific symptoms (note this figure excludes those studies detailed above which consider report EQ-5D values by FEV 1 % level as discussed above). Undertaking an economic evaluation which attempts to quantify the HRQoL impact of a selection of AEs but ignores others would inevitably result in bias, however the direction of such bias would be unclear.…”
Section: Assessment Of Cost-effectivenessmentioning
confidence: 99%